Nemo-Like Kinase Antikörper (Middle Region)
-
- Target Alle Nemo-Like Kinase (NLK) Antikörper anzeigen
- Nemo-Like Kinase (NLK)
-
Bindungsspezifität
- Middle Region
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Nemo-Like Kinase Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Purified
- Immunogen
- NLK antibody was raised in rabbit using the middle region of NLK as the immunogen
- Top Product
- Discover our top product NLK Primärantikörper
-
anti-Nemo-Like Kinase (NLK) (AA 416-515) antibody
NLK Reaktivität: Human WB, ELISA, PLA Wirt: Maus Monoclonal 2B11 unconjugated
anti-Nemo-Like Kinase (NLK) antibodyNLK Reaktivität: Human WB, IF, IHC (p), ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Nemo-Like Kinase (NLK) (AA 275-300) antibodyNLK Reaktivität: Human WB, IF, FACS Wirt: Kaninchen Polyclonal RB16621 unconjugated
anti-Nemo-Like Kinase (NLK) (AA 408-436), (C-Term) antibodyNLK Reaktivität: Human, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal RB34651 unconjugated
anti-Nemo-Like Kinase (NLK) antibodyNLK Reaktivität: Human WB, IHC Wirt: Kaninchen Monoclonal unconjugated
anti-Nemo-Like Kinase (NLK) (AA 278-527) antibodyNLK Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Nemo-Like Kinase (NLK) (AA 278-527) antibodyNLK Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Nemo-Like Kinase (NLK) (AA 406-436), (C-Term) antibodyNLK Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB3358 unconjugated
anti-Nemo-Like Kinase (NLK) (AA 1-515) antibodyNLK Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-Nemo-Like Kinase (NLK) (N-Term) antibodyNLK Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
NLK Blocking Peptide, catalog no. 33R-8051, is also available for use as a blocking control in assays to test for specificity of this NLK antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Target
- Nemo-Like Kinase (NLK)
- Andere Bezeichnung
- NLK (NLK Produkte)
- Synonyme
- Amf antikoerper, Gpi1 antikoerper, AI194375 antikoerper, nlk antikoerper, nlkb antikoerper, zgc:111875 antikoerper, Xnlk antikoerper, nlk1 antikoerper, nlk2 antikoerper, NLK antikoerper, nemo-like antikoerper, RGD1561602 antikoerper, glucose-6-phosphate isomerase antikoerper, nemo like kinase antikoerper, nemo-like kinase, type 1 antikoerper, nemo-like kinase L homeolog antikoerper, Nemo-Like kinase antikoerper, nemo-like kinase antikoerper, Gpi antikoerper, NLK antikoerper, Nlk antikoerper, nlk1 antikoerper, nlk.L antikoerper, nlk antikoerper, nemo-like antikoerper
- Hintergrund
- NLK has a role in cell fate determination, required for differentiation of bone marrow stromal cells. NLK acts downstream of MAP3K7 and HIPK2 to negatively regulate the canonical Wnt/beta-catenin signaling pathway and the phosphorylation and destruction of the MYB transcription factor. NLK may suppress a wide range of transcription factors by phosphorylation of the coactivator, CREBBP By similarity. Synonyms: Polyclonal NLK antibody, Anti-NLK antibody, nemo-like kinase antibody, DKFZp761G1211 antibody, FLJ21033 antibody.
- Pathways
- Ubiquitin Proteasome Pathway
-
